AC
IART icon

Allstate Corporation’s Integra LifeSciences IART Stock Holding History

Allstate Corporation’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
61,292
+16,886
+38% +$236K 0.01% 711
2026
Q1 		$418K Buy
+44,406
New +$488K ﹤0.01% 1032

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Allstate Corporation's IART Position: Q2 2026 in Review

Allstate Corporation increased its Integra LifeSciences (IART) stake by 38% in Q2 2026, buying an estimated $236K and bringing the position to 61,292 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #711.

Allstate Corporation first reported a position in IART in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Allstate Corporation held 61,292 shares of Integra LifeSciences worth $1.1M as of Q2 2026.
  • Allstate Corporation bought 16,886 Integra LifeSciences shares in Q2 2026, an estimated $236K.
  • Integra LifeSciences made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #711 holding.
  • Allstate Corporation first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.